37.60000 EUR
0.6
1.57%
Last update Dec 18, 7:37 PM CET
Market closed
Day range
37.20000
39.60000
Previous close
38.20000
Open
38
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
37.60
0.60
1.57%

Statistics

Valuation metrics
Market cap
0
Enterprise value
49.70M
Trailing P/E (ttm)
-4.32
Forward P/E
PEG ratio
0.14
Price/Sales (ttm)
0
Price/Book (mrq)
8.37
Enterprise Value/Revenue
0.59
Enterprise Value/EBITDA
-0.52
Overview
Shares outstanding
19.65M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
Average volume (90 days)
Price summary
52-Week low
6.06
52-Week high
57
52-Week change
62.80 1,036.8%
Beta
50-Day moving average
50.22
200-Day moving average
24.97
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
68.82%
Operating margin
-92.54%
Operational effectiveness
Return on assets
-39.15%
Return on equity
-195.86%
Income statement
Revenue (ttm)
83.88M
Revenue per share (ttm)
7.18
Quarterly revenue growth (yoy)
5.50%
Gross profit (ttm)
57.73M
EBITDA
0
Net income to common (ttm)
-101.38M
Diluted EPS (ttm)
-8.70
Quarterly earnings growth (yoy)
-51.82%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
78.33M
Total Debt/Equity (mrq)
1.08
Current ratio (mrq)
424.11%
Book value per share (mrq)
4.49
Cash flow
Cash flow statement
-124.50M
Levered free cash flow (LFCF)
-101.38M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 hours 13 minutes

20:46
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).